Table 2.
All children diagnosed with TB during the study period, differentiating between those diagnosed before and after HAART initiation
| Children treated for TB | TB diagnosed <9 months prior to HAART | TB diagnosed <6 months after HAART | TB diagnosed ≥6 months after HAART | |
| Total number# | 137 (100%) | 116 (100%) | 14 (100%) | 7 (100%) |
| Gender: Male | 64 (47%) | 54 (47%) | 6 (43%) | 4 (57%) |
| Age (months): | ||||
| Range/median | 2–140/18 | 2–135/20 | 3–140/17 | 3–75/17 |
| HIV staging | ||||
| WHO* CD4 depletion | ||||
| not significant | 5 (4%) | 3 (3%) | 1 (7%) | 0 (0%) |
| mild | 9 (7%) | 7 (6%) | 0 (0%) | 2 (29%) |
| advanced | 10 (7%) | 7 (6%) | 2 (14%) | 1 (14%) |
| severe | 113 (82%) | 98 (84%) | 11 (79%) | 4 (57%) |
| WHO clinical stage | ||||
| II | 1 (1%) | 0 (0%) | 1 (7%) | 0 (0%) |
| III | 47 (34%) | 40 (34%) | 5 (36%) | 2 (29%) |
| IV | 89 (65%) | 76 (66%) | 8 (57%) | 5 (71%) |
| Weight categories | ||||
| <60% EWA** | 27 (20%) | 24 (21%) | 3 (21%) | 0 (0%) |
| 60–80% EWA | 64 (47%) | 51 (44%) | 7 (50%) | 6 (86%) |
| 80–100% EWA | 34 (25%) | 31 (27%) | 3 (21%) | 0 (0%) |
| >100% EWA | 6 (4%) | 5 (4%) | 1 (7%) | 0 (0%) |
| Unknown | 6 (4%) | 5 (4%) | 0 (0%) | 1 (14%) |
| Previous TB | ||||
| 1 episode | 18 (13%) | 12 (10%) | 5 (36%) | 1 (14%) |
| ≥2 episodes | 7 (5%) | 4 (3%) | 1 (7%) | 2 (29%) |
#4 folders with incomplete data excluded. 1 child with 2 TB episodes is represented twice.
*WHO, World Health Organization immunological classification of HIV-associated immunodeficiency in infants and children, 2006
**EWA, expected weight for age